Provided by Tiger Trade Technology Pte. Ltd.

Cypherpunk Technologies Inc.

2.37
-0.0800-3.27%
Volume:2.29M
Turnover:5.29M
Market Cap:255.40M
PE:-361.06
High:2.39
Open:2.29
Low:2.25
Close:2.45
52wk High:3.70
52wk Low:0.2770
Shares:107.76M
Float Shares:75.06M
Volume Ratio:6.91
T/O Rate:3.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0066
EPS(LYR):0.0700
ROE:-1.21%
ROA:-13.79%
PB:1.83
PE(LYR):33.86

Loading ...

Cypherpunk Technologies is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
1 hour ago

Cypherpunk Technologies price target raised to $4.90 from $1.60 at Cantor Fitzgerald

TIPRANKS
·
1 hour ago

Cypherpunk Regains NASDAQ Compliance with $1 Minimum Bid Price Rule

Reuters
·
Sep 03

Cypherpunk Director Thomas John Dietz Sells 20,000 Common Shares for $34,400

Reuters
·
Aug 28

Cypherpunk Technologies Price Target Maintained with a $1.60/Share by Cantor Fitzgerald

Dow Jones
·
Aug 27

Cypherpunk Technologies Files Form 3 for Head of Mining Kevin Zhang Stake

Reuters
·
Aug 25

Analysts Are Bullish on Top Financial Stocks: Ares Capital (ARCC), Cypherpunk Technologies (CYPH)

TIPRANKS
·
Aug 24

Top Premarket Gainers

MT Newswires Live
·
Aug 24

Cypherpunk Technologies is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Aug 19

Cypherpunk Technologies: Launches Cypherpunk Mining Through a $33.33 Million Equity-Based Transaction with Winklevoss Capital

THOMSON REUTERS
·
Aug 18

Cypherpunk Names Kevin Zhang Head of Mining

Reuters
·
Aug 18

Cypherpunk Technologies Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Cypherpunk Technologies Q2 Adj. EPS $(0.03), Inline

Benzinga Earnings
·
Aug 12

Cypherpunk Technologies Swings to Q2 Profit on Zcash Gains

Reuters
·
Aug 12

Cypherpunk Q2 FY26 Net Income Swings to $39.4 Million; Operating Loss Narrows to $4.69 Million

Reuters
·
Aug 12

Cypherpunk Technologies Inc Q2 Net Income USD 39.4 Million

THOMSON REUTERS
·
Aug 12

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 12

Cypherpunk Unit Leap Therapeutics Reports DeFianCe Phase 2 Sirexatamab Results Published in Clinical Cancer Research

Reuters
·
Aug 12

Cypherpunk Technologies Inc Expected to Post a Loss of 3 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Cypherpunk Technologies Gets NASDAQ Notice After Shares Trade Below $1 Minimum Bid Price

Reuters
·
Jul 22